期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 59, 期 7, 页码 4331-4335出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00127-15
关键词
-
资金
- Astellas
- Pfizer
- Merck
- Gilead
- MSD
- Basilea
Azole resistance in Aspergillus fumigatus is an emerging public health concern. Recently, a novel fungicide-driven mutation in the cyp51A gene and its promoter, TR46/Y121F/T289A, leading to high-level resistance to voriconazole has been identified in The Netherlands, Belgium, Germany, Denmark, Tanzania, and India in both clinical and environmental samples. Here we report the first description of A. fumigatus carrying this mutation in France, in a cystic fibrosis patient, underlining the need for extensive monitoring of Aspergillus resistance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据